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1. Objectives of the protocol
To outline the clinical indications for electron beam
computed tomography (EBCl) scans and the indications for
which funding is appropriate in the following areas:
• use as a CT scanner
• use as a diagnostic aid in cardiology for coronary artery
calcium scoring
• other uses as a diagnostic aid in cardiology.
2. Introduction
In 1997 an EBCT scanner was introduced into South Africa.
Controversy surrounded the introduction of the technology
and positions rapidly became polarised. This culminated in
the Representative Association of Medical Schemes (RAMS)
recommending non-payment for third-party funding claims,
and legal action against a number of groups was advocated.
In the interests of conciliation and fairness the Medical
Association of South Africa (MASA) as represented by Or E
M Barker (Chairperson, Committee for Science and
Education) facilitated the discussions.
When making a decision to introduce an expensive and
new technology, it would be ideal if the introduction and
usage were based on a clinical gUideline linked to a
technology assessment and systematic review of the
literature. Clearly this process was not followed in this
instance, resulting in the current conflict. The
acknowledgment of this problem is not to apportion blame
or be divisive, but rather to clarify for the future. It is very
easy to be wise after one has been confronted with a
difficult situation.
MASA is very keen to facilitate resolution of the above
difficulties without resorting to litigation and further very
costly negotiations, and for this reason became involved in
the current controversy.
A funding protocol simply states the clinical indications
for a particular procedure or treatment so that funders of
health care may make an informed decision on
reimbursement. It is only developed as an interim document
until a full technology assessment and/or clinical guideline is
available. Neither the development of a new systematic
review nor the development of a national clinical guideline is
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a short-term solution. The methodology used to develop a
funding protocol is much shorter and simpler than that for a
clinical guideline. It represents a very abbreviated but
audited process that has allowed the South African medical
profession to study the matter by:
• having access to selected literature
• discussing with international and local content experts
• attending international symposia
• providing a neutral facilitation process
• engaging national specialist groups in a dialogue.
This funding protocol represents the best possible
solution to a difficult situation and MASA recognises that the
process is not ideal (see comments in Annexure A).
However, every care has been taken in the past 8 months to
ensure that the protocol is as unbiased, non-prescriptive
and clear as possible.
The funding protocol is not prescriptive and each funder
will have to make its own decision about whether to include
EBCT scans as a benefit.
It is recommended that a strategy/policy for the
introduction of expensive technology is agreed in
partnership with all stakeholders including the Department
of Health, RAMS, other funders, and medical professional
groups.
Comment(s) for noting should be directed to the
corresponding author.
3. EBCT scanner used as
conventional CT scanner
• An EBCT scanner may be used as a conventional CT
scanner in conditions where CT scanning is usually
indicated.
• The motivation procedure and tariff codes and
reimbursements are the same as for conventional CT
scans.
4. Coronary artery calcium
assessment by EBCT
indications
The presence of coronary artery calcification is associated
with the presence of coronary atheroma. EBCT is a sensitive
method for detecting coronary artery calcification. EBCT is
not a functional test (nuclear medicine stUdy or dobutamine
echo), and therefore a positive test does not imply that the
calcified lesion is causing ischaemia.
4.1 In symptomatic patients
A coronary artery calcium score exceeding that predicted for
the age and gender of the patient can provide supportive
evidence of the presence of coronary artery disease in
patients wro:
4.1.1 have presented with a chest pain syndrome
suggesting cardiac ischaemia
AND
4.1.2.1 in whom alternative non-invasive testing has yielded
an unexpected negative result




4.1.2.2 in whom alternative non-invasive testing would be
unhelpful in arriving at the diagnosis due to:
• physical disability (e.g. dyspnoea at rest, lower limb
amputation or orthopaedic disability), when an alternative
functional study is not available
OR
• abnormalities in the resting electrocardiogram which
prohibit the interpretation of an ischaemic change (e.g. left
bundle-branch block, Wolff-Parkinson-White syndrome,
left ventricular hypertrophy or concomitant digitalis
administration) or the interpretation of an alternative
functional test.
These studies are helpful only in men under 60 years of
age and women under 70 years of age.
This investigation is inappropriate in any patient in whom
coronary artery disease has been identified previously.
A positive coronary artery calcium score is not an
indication for coronary angiography and/or a coronary
revascularisation procedure.
It is appropriate to reimburse coronary artery calcium
assessment performed for the above indications under
code 3598.
To qualify for reimbursement the patieAt must have been
referred by a cardiologist or a specialist physician who is
knowledgeable regarding the management of patients with
coronary artery disease.
Requests to third-party payers for reimbursement must be
accompanied by a written motivation from the referring
doctor, who shall indicate the reason/s for the investigation.
The third-party payers shall establish a data base to
collect and collate information about the performance of
coronary artery calcium assessment which will be available
to the profession to enable peer review.
4.2 In asymptomatic subjects
Coronary artery calcium assessment cannot be
recommended for screening of asymptomatic subjects at
this time as the implication of a positive score with regard to
subsequent management and outcome is unknown.
It is inappropriate for third-party payers to reimburse
coronary artery calcium assessment performed in the
asymptomatic subject.
5. Potential uses of EBCT in
cardiology (excluding coronary
artery calcium assessment)
Because EBCT has the advantage of ultrafast image
acquisition, its capabilities exceed those of standard CT
investigations in the evaluation of the cardiac patient. It is
able to freeze cardiac motion and, with its higher resolution,
detect smaller structures.
The potential applications of EBCT in cardiology already






• improved resolution imaging of
(a) cardiac structures (especially in relation to congenital





(i) coronary artery bypass graft patency
(ii) stent patency
• myocardial perfusion
• visualisation of great vessels
(a) centrally located pulmonary emboli
(b) aortic coarctation
(c) dissecting haematoma of the aorta.
Most of the above investigations can also be performed
with alternative modalities, e.g. echocardiography, stress
echocardiography, radio-isotope ventriculography, radio-
isotope myocardial perfusion imaging, pulmonary perfusion-
ventilation scanning, angiography, standard CT and
magnetic resonance imaging. The cost-effectiveness ranking
of EBCT compared with these other diagnostic methods has
not yet been established. These alternative uses of EBCT
make up a very small percentage of the total cardiac
caseload in established units.
Certain of these EBCT investigations require the use of X-
ray contrast media.
Reimbursement of such EBCT investigations by third-
party payers is warranted provided motivation has been
provided by the referring cardiologist, paediatric cardiologist
or physician with a special interest in cardiology which
specifically indicates why in the particular instance EBCT
was preferred to an alternative technology.
6. Endorsements
This final funding protocol is endorsed by the following
national professional groups:
• South African Society of Cardiac Practitioners (SASCP)
• Southern African Cardiac Society (SACS)
• Radiological Society of South Africa (RSSA).
Neither the Department of Health nor RAMS wished to
endorse the draft funding protocol, and their full statements
are enclosed (annexures A and B respectively).
Endorsements by individuals were noted. The revisions to
the document were again circulated to the professional
groups and Pretoria HeartScan before publication. All have
endorsed the document.
7. List of EBCT Working Group
Attended meeting on 22 February 1998:
Or E M Barker, Chairperson, MASA
Or V B Andrijich, RSSA
Or C J Botha, Aerospace Medical Society of South Africa
Prof. P Corr, RSSA
Or A J Dalby, SASCP
Or A Dasoo, RAMS
Or F de Beer, Medical Advisors Group
Or C Hugo-Hamman, Department of Health
Or lilies, Pretoria HeartScan*
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Dr D G King, Imatron, USA*
Dr P Mavengere, Medical Advisors Group
Dr T J Nel, Pretoria HeartScan*
Ms V J Pinkney-Atkinson, Centre for Quality Care, MASA
Ms E Prins, Health Policy, Economics and Private Practice,
MASA
Dr Rumberger, international content expertt
Dr J Swartzberg, Pretoria HeartScan*
Dr R Tuft, RSSA
Dr M Versache, Pretoria Heart Hospital*
Dr C van Wyk, Pretoria Heart Hospital*
"Financial interest in the EBCT machine or in the manufacturing company.
tFinancial interest or fee for presentation not clarified despite request for
such information.
Did not attend meeting:
Dr E Klug, MASA Committee for Science and Education
nominee
Prof. P Manga, SACS
Mr B Pharasi, Department of Health
Prof. A D Rothberg, Guideline Committee, MASA
Dr A J Snyman, Guideline Committee, MASA
Dr L Steingo, SACS





The Department of Health funded the participation of its
delegate.
9. Methodology
During the course of meetings and discussion about the
funding of EBCT it was agreed that a funding protocol
should be developed for use by third-party funders
specifically in relation to coronary artery calcium
assessments. The funding protocol development
methodology is shorter than that of a national clinical
guideline. There are numerous differences in the
methodology, but in essence it is less rigorous, takes less
time and involves a smaller segment of the profession.
However, it serves the purpose of outlining indications for
EBCT scanning other than coronary artery calcium scoring
using a combination of consensus and evidence-based
strategies.
A list of working group participants was developed
including those with financial interest and representatives of
professional disciplines who may use the output of EBCT
scanners and funders who would be requested to pay for
EBCT scanner usage. All participants were supplied with the
relevant documentation. Each participant completed a
declaration about their own financial interest in the
technology, and these are noted in the participant list.
After the meeting a draft document was written up by
Dr T J Nel and this was circulated to all participants for
comment and endorsement. The comment and
endorsement process continued from November 1997 to the
end of April 1998. The collation of the comments and this
final draft has been facilitated by the MASA Centre for
Quality Care. The final funding protocol is sUbstantially
different from that developed by Dr Nel and has been
endorsed by the major professional groups and Pretoria
HeartScan.
This report will be available on the Internet at the Health
Channel site (www.hc.co.za/quality) and will be available to
the funders of health care on request.
The Executives of the SACP and SACS have produced
statements on EBCT. Much of these has been incorporated
into the funding protocol, but they are also available on
request.
10. Disclaimer
This funding protocol is for reference and education only
and is not intended to be a substitute for the advice of the
appropriate health care professional or for independent
research and judgement. The MASA relies on the source of
the funding protocol to provide updates and to notify us if
the protocol becomes outdated. The MASA assumes no
responsibility or liability arising from any outdated
information or from any error in or omission from the
protocol or from the use of any information contained in it.
Annexure A. Submission from
the Department of Health
The controversy over electron beam computed tomography
(EBCT) has raised concerns which have gone beyond the
utility to be derived from the use of the technology in any
given set of clinical circumstances. Some concerns are
generic to all sophisticated health care technologies, while
others are particular to EBCT. These issues are of such
fundamental concern to the practice of medicine and to the
health system in general, that it is our view that any
discussion of clinical application cannot take place without
due consideration of them.
1. Ownership
The Department of Health opposes the practice
whereby referring physicians have a financial interest in
the equipment and/or services which they requisition
for their patients. The objections are based on the belief
that this creates a potential moral hazard where the
likely financial return becomes an important factor that
may obscure any genuine, scientifically based,
biomedical criteria for the procedure or intervention.
This would not be in the best interests of the patient or
of society at large. Such self-ownership also
contributes to over-utilisation of these services and
therefore to the overall costs of care.
This is true of many technologically based diagnostic
or therapeutic interventions. Today the debate concerns
EBCT. Tomorrow it may be elsewhere, for example
orthopac<Jic surgeons with shareholdings in magnetic
resonance imaging facilities.
2. Self-referral
EBCT has been marketed directly to the public by the
provider as a useful screening procedure for
asymptomatic patients at risk of coronary artery
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disease. The veracity of this particular claim has been
challenged by the representative societies of specialist
cardiologists in South Africa and abroad.
The Department of Health is in general opposed to
self-referral for expensive, sophisticated, technology-
based procedures (such as EBCT). The public may not
be adequately informed about the procedure and their
interests are of paramount concern. We believe that
only adequately and appropriately qualified
professionals who are familiar with and understand the
complex issues relating to the usage of these
procedures and interpretation of the results should be
requesting these investigations. They can then be held
professionally responsible for the decision to
recommend the procedure and they are best placed to
provide appropriate counselling in the presence of both
positive and negative results.
From a concern for overall costs of care, we believe
that self-referral lends itself to inappropriate utilisation
and overutilisation of these diagnostic modalities.
3. Need
Health care technology assessment should guide the
acquisition, distribution and utifisation of health care
technologies so that issues of need, equity in access,
cost-benefit and cost efficacy can be addressed. These
concerns apply equally to publicly and privately funded
health care. We are acutely aware that any 'agreement'
on the utilisation of this particular machine will be used
by other parties to justify further investments in EBCT
at other facilities. Therefore the desire to ensure that the
final opinion on the protocols is well considered.
4. Indications for ESCT
There are fundamentally opposing views on the
application of EBCT in coronary artery disease.
Whereas advocates argue strongly for its use even in
asymptomatic patients, in their submission of 27
February 1998 the South African Society of Cardiac
Practitioners wrote, 'It [EBCT] does not presently merit
a position in the investigative armamentarium of
practising cardiologists.' For their part, the South
African Cardiac Society wrote, 'There is insufficient data
to recommend coronary artery calcium scoring in lieu of
stress testing ... in patients with chest pain.' These
views are supported by the Representative Association
of Medical Schemes in their independent assessment
of the technology in 1997.
The Department of Health believes that clinical care
should be based upon an analysis of the best available
evidence. In the absence of a systematic review of the
evidence for EBCT (which we regard as being the key
component of health care technology assessment), the
Department of Health will be gUided by international
practice and the appropriate expert, professional,
cardiological and radiological societies of South Africa.
Consensus has now been reached between these
groups on indications for EBCT for use as:
• a conventional CT scanner
• for coronary artery calcium assessment in
symptomatic patients, and
• for other cardiological indications.
The protocol has excluded the use of EBCT for
coronary artery assessment in the large groups of
asymptomatic but at-risk patients.
The protocol has also effectively ruled out self-referral
and has recommended to third-party payers that
referral by an appropriately qualified and experienced
medical specialist should be a precondition to requests
for reimbursement. This is a welcome development with
significant implications for the reimbursement of other
diagnostic and therapeutic procedures.
Conclusion. The protocol has not by definition addressed
concerns of ownership, or of equity, need and cost-
effectiveness. The Department of Health aims to address
issues of ownership of facilities and equipment through
other mechanisms. It reserves its judgement on the benefits
of EBCT until such time as a proper systematic review and




Annexure B. Comments from
RAMS
The funding proposal on EBCT sent to RAMS and other
interested parties refers, and I wish to respond as follows:
1. The clinical relevance of EBCT is still the subject of much
debate, both locally and abroad, and until such time as
there is sufficient consensus on the technology and the
conditions for which its use is indicated, our position
remains as we have stated before.
2. RAMS therefore, even in the light of further extensive
lobbying by interested parties, holds that no
recommendation for reimbursement will be made to
member schemes referable to the use of this machine,
except where it is used as a conventional CT scanner in
conditions where CT scanning is usually indicated. In this
instance, existing CT codes and reimbursement levels in
the Scale of Benefits will suffice.
3. RAMS will only reconsider its position in the light of
substantial clinical consensus on this technology within
the medical fraternity, but will predicate any shift in
position on the financial impact on medical schemes and
in keeping with the emergent technology regulatory
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